HOME Top Market Reports Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: MD 3680

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period. The injectable drug delivery market is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions.

The major factors responsible for the growth of this market are the increasing use of biologics, increase in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors. On the other hand, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.

North America is projected to dominate the market in 2016, with the U.S. accounting for a major share. However, Asia is expected to grow at the highest CAGR during the forecast period. This growth is attributed to rising incidence of chronic and autoimmune diseases and rising aging population. Also, high penetration of self-injection techniques and technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices in the region.

Apart from the comprehensive geographical analysis, product analysis, and market sizing; the report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach, R&D investments for innovations in products and technology, and levels of output to remain successful.

The injectable drug delivery market is growing with good pace with various players. Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

Target Audience:

  • Injectable drug delivery manufacturers
  • Public and private physicians
  • Healthcare institutions (Medical data centers)
  • Research & clinical laboratories
  • Distributors and suppliers of injectable drug delivery devices
  • Health insurance payers
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the Injectable drug delivery market into the following segments and subsegments.

Injectable Drug Delivery Market, by Type

  • Devices
  • Formulations

Injectable Drug Delivery Market, by Formulation Packaging

  • Ampules
  • Vials
  • Cartridges
  • Bottles

Injectable Drug Delivery Market, by Therapeutic Application

  • Auto-immune diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Oncology
  • Other Therapeutic Applications

Injectable Drug Delivery Market, by Usage Pattern

  • Curative Care
  • Immunization
  • Other Usage Pattern

Injectable Drug Delivery Market, by Site of Administration

  • Skin
  • Circulatory/Musculoskeletal
  • Organs
  • Central Nervous System

Injectable Drug Delivery Market, by Distribution Channel

  • Hospitals
  • Retail Pharmacy Stores

Injectable Drug Delivery Market, by Facility of Use

  • Hospitals & Clinics
  • Home Care Settings
  • Other Facilities of Use

Injectable Drug Delivery Market, by Region  

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia
    • China
    • India
    • Japan
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5).

Further Split of the RoW Injectable Drug Delivery Market

Injectable drug delivery market size and growth rate estimates of Latin America, Pacific, and the Middle East & Africa.

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 27)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 37)
    4.1 Market Overview
    4.2 Injectable Drug Delivery Market, By Facility of Use
    4.3 Geographic Analysis: By Site of Administration
    4.4 Injectable Drug Delivery Market, By Formulation Packaging
    4.5 Geographical Snapshot

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Chronic Diseases
                    5.2.1.2 Increase in Demand for Self-Injection Devices
                    5.2.1.3 Growth in the Biologics Market
                    5.2.1.4 Technological Advancements and New Product Launches
           5.2.2 Restraints
                    5.2.2.1 Infections Associated With Needlestick Injuries
                    5.2.2.2 Product Recalls
           5.2.3 Opportunities
                    5.2.3.1 Increase in Demand for Biosimilar and Generic Injectables
                               5.2.3.1.1 Biosimilars
                               5.2.3.1.2 Generic Injectables
                    5.2.3.2 Contraceptive Injectables
           5.2.4 Challenge
                    5.2.4.1 Preference for Other Modes of Drug Delivery

6 Regulatory Scenario (Page No. - 49)
    6.1 Introduction
    6.2 FDA and CE Approvals
    6.3 The European Medicines Agency (EMA)
    6.4 Clinical Trials

7 Injectable Drug Delivery Market, By Type (Page No. - 51)
    7.1 Introduction
    7.2 Devices
           7.2.1 Conventional Injection Devices
                    7.2.1.1 By Material
                               7.2.1.1.1 Glass
                               7.2.1.1.2 Plastic
                    7.2.1.2 By Product
                               7.2.1.2.1 Fillable Syringes
                               7.2.1.2.2 Prefilled Syringes
                    7.2.1.3 By Usability
                               7.2.1.3.1 Reusable Injection Devices
                               7.2.1.3.2 Disposable Injection Devices
           7.2.2 Self-Injection Devices
                    7.2.2.1 Needle-Free Injectors
                               7.2.2.1.1 By Product
                                             7.2.2.1.1.1 Fillable Needle-Free Injectors
                                             7.2.2.1.1.2 Prefilled Needle-Free Injectors
                               7.2.2.1.2 By Technology
                                             7.2.2.1.2.1 Jet-Based Needle-Free Injectors
                                             7.2.2.1.2.2 Spring-Based Needle-Free Injectors
                                             7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
                                             7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
                               7.2.2.1.3 By Usability
                                             7.2.2.1.3.1 Reusable Needle-Free Injectors
                                             7.2.2.1.3.2 Disposable Needle-Free Injectors
                    7.2.2.2 Autoinjectors
                               7.2.2.2.1 By Product
                                             7.2.2.2.1.1 Fillable Autoinjectors
                                             7.2.2.2.1.2 Prefilled Autoinjectors
                               7.2.2.2.2 By Technology
                                             7.2.2.2.2.1 Automated Autoinjectors
                                             7.2.2.2.2.2 Manual Autoinjectors
                               7.2.2.2.3 By Design
                                             7.2.2.2.3.1 Standardized Autoinjectors
                                             7.2.2.2.3.2 Customized Autoinjectors
                               7.2.2.2.4 By Usability
                                             7.2.2.2.4.1 Reusable Autoinjectors
                                             7.2.2.2.4.2 Disposable Autoinjectors
                    7.2.2.3 Pen Injectors
                               7.2.2.3.1 By Product
                                             7.2.2.3.1.1 Single-Chambered Pen Injectors
                                             7.2.2.3.1.2 Dual-Chambered Pen Injectors
                               7.2.2.3.2 By Design
                                             7.2.2.3.2.1 Standard Pen Injectors
                                             7.2.2.3.2.2 Customized Pen Injectors
                               7.2.2.3.3 By Usability
                                             7.2.2.3.3.1 Reusable Pen Injectors
                                             7.2.2.3.3.2 Disposable Pen Injectors
                    7.2.2.4 Wearable Injectors
                    7.2.2.5 Other Devices
    7.3 Formulations
           7.3.1 Conventional Drug Delivery Formulations
                    7.3.1.1 Solutions
                    7.3.1.2 Reconstituted/Lyophilized Formulations
                    7.3.1.3 Suspensions
                    7.3.1.4 Emulsions
           7.3.2 Novel Drug Delivery Formulations
                    7.3.2.1 Colloidal Dispersions
                               7.3.2.1.1 Niosomes
                               7.3.2.1.2 Liposomes
                               7.3.2.1.3 Polymeric/Mixed Micelles
                               7.3.2.1.4 Nanoparticles
                                             7.3.2.1.4.1 Solid-Lipid Nanoparticles
                                             7.3.2.1.4.2 Nanosuspensions
                                             7.3.2.1.4.3 Nanoemulsions
                    7.3.2.2 Microparticles
                               7.3.2.2.1 Microspheres
                               7.3.2.2.2 Microcapsules
           7.3.3 Long-Acting Injection Formulations

8 Injectable Drug Delivery Market, By Formulation Packaging (Page No. - 100)
    8.1 Introduction
    8.2 Ampules
    8.3 Vials
    8.4 Cartridges
    8.5 Bottles

9 Injectable Drug Delivery Market, By Therapeutic Application (Page No. - 104)
    9.1 Introduction
    9.2 Autoimmune Diseases
           9.2.1 Rheumatoid Arthritis
           9.2.2 Multiple Sclerosis (MS)
           9.2.3 Crohn’s Disease
           9.2.4 Psoriasis
           9.2.5 Other Autoimmune Diseases
    9.3 Hormonal Disorders
           9.3.1 Diabetes
           9.3.2 Anemia
           9.3.3 Reproductive Health Disease
           9.3.4 Antithrombotic/Thrombolytic Therapy
           9.3.5 Osteoporosis
           9.3.6 Growth Hormone Deficiency (GHD)
    9.4 Orphan Diseases
    9.5 Cancer
    9.6 Other Therapeutic Applications
           9.6.1 Pain Management
           9.6.2 Allergies
           9.6.3 Aesthetic Treatment
           9.6.4 Hepatitis C
           9.6.5 Hemophilia

10 Injectable Drug Delivery Market, By Usage Pattern (Page No. - 125)
     10.1 Introduction
     10.2 Curative Care
     10.3 Immunization
     10.4 Others

11 Injectable Drug Delivery Market, By Site of Administration (Page No. - 130)
     11.1 Introduction
     11.2 Skin (Intradermal and Subcutaneous)
     11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
     11.4 Organs (Intravitreal and Intra-Articular)
     11.5 Central Nervous System (Intracerebral and Intrathecal)

12 Injectable Drug Delivery Market, By Distribution Channel (Page No. - 136)
     12.1 Introduction
     12.2 Hospitals
     12.3 Retail Pharmacy Stores

13 Injectable Drug Delivery Market, By Facility of Use (Page No. - 139)
     13.1 Introduction
     13.2 Hospitals and Clinics
     13.3 Home Care Settings
     13.4 Other Facilities of Use

14 Injectable Drug Delivery Market, By Region (Page No. - 144)
     14.1 Introduction
     14.2 North America
             14.2.1 U.S.
             14.2.2 Canada
     14.3 Europe
             14.3.1 Germany
             14.3.2 France
             14.3.3 U.K.
             14.3.4 Italy
             14.3.5 Spain
             14.3.6 Rest of Europe (RoE)
     14.4 Asia
             14.4.1 China
             14.4.2 Japan
             14.4.3 India
             14.4.4 Rest of Asia
     14.5 Rest of the World (RoW)

15 Competitive Landscape (Page No. - 215)
     15.1 Overview
     15.2 Market Share Analysis
     15.3 Competitive Situation and Trends
             15.3.1 Partnerships, Agreements, and Collaborations
             15.3.2 Product Launches, Approvals, and Enhancements
             15.3.3 Expansions
             15.3.4 Acquisitions

16 Company Profiles (Page No. - 221)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     16.1 Introduction
     16.2 Baxter International, Inc.
     16.3 Becton, Dickinson and Company
     16.4 Gerresheimer AG
     16.5 Pfizer, Inc.
     16.6 Schott AG
     16.7 ELI Lilly and Company
     16.8 Sandoz (A Division of Novartis AG)
     16.9 Terumo Corporation
     16.10 Teva Pharmaceutical Industries Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

17 Appendix (Page No. - 245)
     17.1 Insights From Industry Experts
     17.2 Discussion Guide
     17.3 Other Recent Developments
     17.4 Available Customizations
     17.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
     17.6 RT: Real-Time Market Intelligence
     17.7 Related Reports
     17.8 Author Details


List of Tables (288 Tables)

Table 1 Product Recalls (2013–2015)
Table 2 Injectable Drugs Going Off-Patent in the U.S.
Table 3 List of Regulatory Authorities in Major Countries
Table 4 List of FDA Approved in the Market (2015-2016)
Table 5 Injectable Drugs in Phase Iii Clinical Trials
Table 6 Product Recalls (2015-2016)
Table 7 Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 8 Injectable Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 9 Injectable Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Conventional Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Conventional Injection Devices Market Size, By Material, 2014–2021 (USD Billion)
Table 12 Conventional Glass Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Conventional Plastic Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Conventional Injection Devices Market Size, By Product, 2014–2021 (USD Billion)
Table 15 Conventional Fillable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 16 Conventional Prefilled Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Conventional Injection Devices Market Size, By Usability, 2014–2021 (USD Billion)
Table 18 Conventional Reusable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Conventional Disposable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 20 Self-Injection Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 21 Self-Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Needle-Free Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 24 Fillable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 25 Prefilled Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Needle-Free Injectors Market Size, By Technology, 2014–2021 (USD Million)
Table 27 List of Some of the Needle-Free Jet Injectors Available in the Market
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 29 List of Some of the Needle-Free Spring-Based Injectors Available in the Market
Table 30 Spring-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 31 Laser-Powered Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 32 Vibration-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 33 Needle-Free Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 34 Reusable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 35 Disposable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 36 Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 37 Autoinjectors Market Size, By Product, 2014–2021 (USD Billion)
Table 38 Fillable Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 39 Prefilled Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 40 Autoinjectors Market Size, By Technology, 2014–2021 (USD Billion)
Table 41 Automated Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 42 Manual Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 43 Autoinjectors Market Size, By Design, 2014–2021 (USD Billion)
Table 44 Standardized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 45 Customized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 46 Autoinjector Market Size, By Usability, 2014–2021 (USD Billion)
Table 47 Reusable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 48 Disposable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 49 Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 50 Commercially Available Pen Injectors
Table 51 Pen Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 52 Single-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 53 Commercially Available Dual-Chambered Pen Injectors
Table 54 Dual-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 55 Pen Injectors Market Size, By Design, 2014–2021 (USD Billion)
Table 56 Standard Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 57 Customized Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 58 Pen Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 59 Reusable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 60 Disposable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 61 Wearable Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 62 Other Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 63 Injectable Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 64 Injectable Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 65 Conventional Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 66 Conventional Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 67 Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 68 Reconstituted/Lyophilized Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 69 Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 70 Emulsions Market Size, By Region, 2014–2021 (USD Billion)
Table 71 Novel Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 72 Novel Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 73 Colloidal Dispersions Market Size, By Type, 2014–2021 (USD Billion)
Table 74 Colloidal Dispersions Market Size, By Region, 2014–2021 (USD Billion)
Table 75 Niosomes Market Size, By Region, 2014–2021 (USD Billion)
Table 76 Liposomes Market Size, By Region, 2014–2021 (USD Billion)
Table 77 Polymeric/Mixed Micelles Market Size, By Region, 2014–2021 (USD Billion)
Table 78 Nanoparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 79 Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 80 Solid-Lipid Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 81 Nanosuspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 82 Nanoemulsions Market Size, By Region, 2014–2021 (USD Million)
Table 83 Microparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 84 Microparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 85 Microspheres Market Size, By Region, 2014–2021 (USD Billion)
Table 86 Microcapsules Market Size, By Region, 2014–2021 (USD Billion)
Table 87 Long-Acting Injection Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 88 Injectable Drug Delivery Market Size, By Formulation Packaging, 2014–2021 (USD Billion)
Table 89 Injectable Drug Delivery Market Size for Formulation Packaging, By Region, 2014–2021 (USD Billion)
Table 90 Injectable Drug Delivery Market Size for Ampules, By Region, 2014–2021 (USD Billion)
Table 91 Injectable Drug Delivery Market Size for Vials, By Region, 2014–2021 (USD Billion)
Table 92 Injectable Drug Delivery Market Size for Cartridges, By Region, 2014–2021 (USD Billion)
Table 93 Injectable Drug Delivery Market Size for Bottles, By Region, 2014–2021 (USD Billion)
Table 94 Injectable Drug Delivery Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
Table 95 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2014–2021 (USD Billion)
Table 96 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 97 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2014–2021 (USD Billion)
Table 98 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2014–2021 (USD Billion)
Table 99 Market Size for Crohn’s Disease, By Region, 2014–2021 (USD Billion)
Table 100 Injectable Drug Delivery Market Size for Psoriasis, By Region, 2014–2021 (USD Billion)
Table 101 Market Size for Other Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 102 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2014–2021 (USD Billion)
Table 103 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2014–2021 (USD Billion)
Table 104 Market Size for Diabetes, By Region, 2014–2021 (USD Billion)
Table 105 Injectable Drug Delivery Market Size for Anemia, By Region, 2014–2021 (USD Billion)
Table 106 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2014–2021 (USD Billion)
Table 107 Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2014–2021 (USD Billion)
Table 108 Injectable Drug Delivery Market Size for Osteoporosis, By Region, 2014-2021 (USD Billion)
Table 109 Injectable Drug Delivery Market Size for Growth Hormone Deficiency, By Region, 2014-2021 (USD Billion)
Table 110 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2014-2021 (USD Billion)
Table 111 Market Size for Cancer, By Region, 2014-2021 (USD Billion)
Table 112 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2014-2021 (USD Billion)
Table 113 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Billion)
Table 114 Injectable Drug Delivery Market Size for Pain Management, By Region, 2014-2021 (USD Billion)
Table 115 Market Size for Allergies, By Region, 2014-2021 (USD Billion)
Table 116 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2014-2021 (USD Million)
Table 117 Injectable Drug Delivery Market Size for Hepatitis C, By Region, 2014-2021 (USD Billion)
Table 118 Injectable Drug Delivery Market Size for Hemophilia, By Region, 2014-2021 (USD Million)
Table 119 Injectable Drug Delivery Market Size, By Usage Pattern, 2014–2021 (USD Billion)
Table 120 Pipeline Curative Care Drugs (2016-2020)
Table 121 Market Size for Curative Care, By Region, 2014–2021 (USD Billion)
Table 122 Injectable Drug Delivery Market Size for Immunization, By Region, 2014–2021 (USD Billion)
Table 123 Injectable Drug Delivery Market Size for Other Usage Patterns, By Region, 2014–2021 (USD Billion)
Table 124 Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 125 Market for Injectable Drug Delivery Through Skin, By Region, 2014–2021 (USD Billion)
Table 126 Market for Injectable Drug Delivery Through Circulatory/Musculoskeletal System, By Region, 2014–2021 (USD Billion)
Table 127 Market for Injectable Drug Delivery Through Organs, By Region, 2014–2021 (USD Billion)
Table 128 Market for Injectable Drug Delivery Through Central Nervous System, By Region, 2014–2021 (USD Billion)
Table 129 Injectable Drug Delivery Market Size, By Distribution Channel, 2014–2021 (USD Billion)
Table 130 Injectable Drug Delivery Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 131 Injectable Drug Delivery Market Size for Retail Pharmacy Stores, By Region, 2014–2021 (USD Million)
Table 132 Injectable Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 133 Injectable Drug Delivery Market Size for Hospitals and Clinics, By Region, 2014–2021 (USD Billion)
Table 134 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 135 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 136 Injectable Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 137 North America: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 138 North America: Market Size, By Type, 2014–2021 (USD Billion)
Table 139 North America: Market Size, By Device, 2014-2021 (USD Billion)
Table 140 North America: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 141 North America: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 142 North America: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 143 North America: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 144 North America: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 145 North America: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 146 North America: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 147 U.S.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 148 U.S.: Market Size, By Device, 2014-2021 (USD Billion)
Table 149 U.S.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 150 U.S.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 151 U.S.: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 152 U.S.: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 153 U.S.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 154 U.S.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 155 U.S.: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 156 List of Injectables Launched in Canada (2014-2015)
Table 157 Canada: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 158 Canada: Market Size, By Device, 2014-2021 (USD Billion)
Table 159 Canada: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 160 Canada: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 161 Canada: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 162 Canada: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 163 Canada: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 164 Canada: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 165 Canada: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 166 Europe: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 167 Europe: Market Size, By Type, 2014-2021 (USD Billion)
Table 168 Europe: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 169 Europe: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 170 Europe: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 171 Europe: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 172 Europe: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 173 Europe: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 174 Europe: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 175 Europe: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 176 Germany: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 177 Germany: Market Size, By Device, 2014-2021 (USD Billion)
Table 178 Germany: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 179 Germany: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 180 Germany: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 181 Germany: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 182 Germany: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 183 Germany: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 184 Germany: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 185 France: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 186 France: Market Size, By Device, 2014-2021 (USD Billion)
Table 187 France: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 188 France: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 189 France: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 190 France: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 191 France: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 192 France: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 193 France: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 194 U.K.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 195 U.K.: Market Size, By Device, 2014-2021 (USD Billion)
Table 196 U.K.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 197 U.K.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 198 U.K.: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 199 U.K.: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 200 U.K.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 201 U.K.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 202 U.K.: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 203 Italy: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 204 Italy: Market Size, By Device, 2014-2021 (USD Million)
Table 205 Italy: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 206 Italy: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 207 Italy: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 208 Italy: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 209 Italy: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 210 Italy: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 211 Italy: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 212 Spain: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 213 Spain: Market Size, By Device, 2014-2021 (USD Million)
Table 214 Spain: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 215 Spain: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 216 Spain: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 217 Spain: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 218 Spain: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 219 Spain: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 220 Spain: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 221 RoE: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 222 RoE: Market Size, By Device, 2014-2021 (USD Billion)
Table 223 RoE: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 224 RoE: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 225 RoE: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 226 RoE: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 227 RoE: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 228 RoE: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 229 RoE: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 230 Asia: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 231 Asia: Market Size, By Type, 2014-2021 (USD Billion)
Table 232 Asia: Market Size, By Device, 2014-2021 (USD Billion)
Table 233 Asia: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 234 Asia: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 235 Asia: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 236 Asia: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 237 Asia: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 238 Asia: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 239 Asia: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 240 China: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 241 China: Market Size, By Device, 2014-2021 (USD Billion)
Table 242 China: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 243 China: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 244 China: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 245 China: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 246 China: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 247 China: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 248 China: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 249 Japan: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 250 Japan: Market Size, By Device, 2014-2021 (USD Billion)
Table 251 Japan: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 252 Japan: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 253 Japan: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 254 Japan: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 255 Japan: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 256 Japan: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 257 Japan: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 258 India: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 259 India: Market Size, By Device, 2014-2021 (USD Billion)
Table 260 India: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 261 India: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 262 India: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 263 India: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 264 India: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 265 India: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 266 India: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 267 RoA: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 268 RoA: Market Size, By Device, 2014-2021 (USD Million)
Table 269 RoA: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 270 RoA: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 271 RoA: Market Size, By Usage Pattern, 2014-2021 (USD Million)
Table 272 RoA: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 273 RoA: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 274 RoA: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 275 RoA: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 276 RoW: Market Size, By Type, 2014-2021 (USD Billion)
Table 277 RoW: Market Size, By Device, 2014-2021 (USD Billion)
Table 278 RoW: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 279 RoW: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 280 RoW: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 281 RoW: Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 282 RoW: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 283 RoW: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 284 RoW: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 285 Partnerships, Agreements, and Collaborations (2013–2016)
Table 286 Product Launches, Approvals, and Enhancements (2013–2016)
Table 287 Expansions (2013–2016)
Table 288 Acquisitions (2013–2016)

List of Figures (34 Figures)

Figure 1 Injectable Drug Delivery Market
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation and Region
Figure 6 Data Triangulation Methodology
Figure 7 Injectable Drug Delivery Market Snapshot, By Formulation 2016 vs 2021 (USD Billion)
Figure 8 Injectable Drug Delivery Market, By Facility of Use 2016 vs 2021 (USD Billion)
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2016 vs 2021 (USD Billion)
Figure 10 Injectable Drug Delivery Market, By Region (2016-2021)
Figure 11 Increasing Use of Biologic Drugs and Rising Prevalence of Chronic Diseases to Drive Market Growth
Figure 12 Hospitals and Clinics to Dominate the Market in 2016
Figure 13 Skin Segment to Command the Largest Market Share in 2016
Figure 14 Ampules to Dominate the Injectable Drug Delivery Market, in 2016
Figure 15 China to Register Highest Growth Rate During the Forecast Period
Figure 16 Market Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia: Market Snapshot
Figure 20 Rest of the World: Market Snapshot
Figure 21 Key Players Adopted Inorganic Growth Strategies Between 2013 and 2016
Figure 22 Market Evolution Framework, 2013–2016
Figure 23 Global Market Share Analysis, 2015
Figure 24 Battle for Market Share: Partnerships, Agreements, and Collaborations are the Key Strategies Adopted By Market Players
Figure 25 Geographic Benchmarking of Top 5 Players
Figure 26 Baxter International, Inc.: Company Snapshot (2015)
Figure 27 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 28 Gerresheimer AG: Company Snapshot (2015)
Figure 29 Pfizer, Inc.: Company Snapshot (2015)
Figure 30 Schott AG: Company Snapshot (2015)
Figure 31 ELI Lilly and Company: Company Snapshot (2015)
Figure 32 Sandoz: Company Snapshot (2015)
Figure 33 Terumo Corporation: Company Snapshot (2015)
Figure 34 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2015)

The global injectable drug delivery market is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period. Growth in this market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, increase in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections.

Furthermore, high penetrations of self-injection techniques, maximum patient compliance, reduction in the frequency of dosage administration without compromising the effectiveness of the treatment and increasing disposable income offer potential opportunities. On the other hand, various increasing complications, such as use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections and needlestick injuries may hinder the growth of the market.

The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions.

Based on site of administration, the market is segmented into skin, circulatory/musculoskeletal system, organs, and central nervous system (CNS). Skin is the fastest-growing segment due to its high efficacy and proven results of skin-based administration of vaccines and drugs such as insulin and morphine.

By usage pattern, the market is segmented into curative care, immunization, and others (blood transfusion, inoculation, blood products, and contraceptives). Curative care is the fastest-growing segment due to the fact that majority of the injections are administered for therapeutic (curative) purposes, rather than immunization (Source: WHO). The factor that drives the growth of this segment is the increasing healthcare access in many countries coupled with the rising prevalence of various diseases.

By type, the market is segmented into formulations and devices. Formulations are the fastest-growing segment due to rising demand for biologics. In addition, the increase in targeted drug R&D activities and the growing positive clinical outcomes of novel formulations such as liposomes, dendrimers, and microspheres for the treatment of chronic diseases are driving the growth of this market.

Based on formulation packaging, the market is segmented into ampules, vials, cartridges, and bottles. Ampules are the fastest-growing segment due to ease of transportation and low cost of manufacturing.

On the basis of therapeutic applications, the market is segmented into autoimmune diseases, hormonal disorders, cancer, orphan diseases, and other therapeutic applications (pain management, allergies, hepatitis C, aesthetic treatment, and hemophilia). Cancer segment is expected to register the highest CAGR during the forecast period. This is attributed to the launch of new vaccines and target therapies, such as antiangiogenics and antineoplastic monoclonal antibodies (mAbs).

By facility of use, the market is segmented into hospitals and clinics, home care settings, and other facilities of use. In 2016, the home care settings segment is expected to grow at the highest CAGR of the market, primarily due to increasing use of home care; reducing the need to travel to healthcare facilities, thus saving time and money for patients. In addition, the growing awareness and patient acceptability of home care increase the trend of self-injection which contributes to the growth of this market in the future.

Injectable Drug Delivery Market

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. This growth in this market is attributed to rising incidence of chronic diseases and growing aging population. In addition, high penetration of self-injection technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices.

Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo